Loading...
Bienvenue dans la collection HAL Infinity
Recherche en Immunologie, Inflammation et Maladies Infectieuses : du fondamental au translationnel
L’Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), créé au 1er janvier 2021, résulte de la fusion de deux unités de recherche localisées sur le campus Purpan, le Centre de Physiopathologie Toulouse Purpan (CPTP) et l’Unité de Différenciation Epithéliale et Autoimmunité Rhumatoïde (UDEAR).
Nombre de fichiers déposés
998
Dernières publications
-
-
Sébastien Lhomme, Cyril Garrouste, Nassim Kamar, Karine Sandres-Sauné, Florence Abravanel, et al.. Influence of Polyproline Region and Macro Domain Genetic Heterogeneity on HEV Persistence in Immunocompromised Patients. Journal of Infectious Diseases, 2025, 209 (2), pp.300-303. ⟨10.1093/infdis/jit438⟩. ⟨hal-04889860⟩
-
-
-
Julie Noguerol, Karl Laviolette, Margot Zahm, Adeline Chaubet, Ambrine Sahal, et al.. Heterochromatic gene silencing controls CD4+ T cell susceptibility to regulatory T cell-mediated suppression in a murine allograft model. Nature Communications, 2025, 16 (1), pp.566. ⟨10.1038/s41467-025-55848-4⟩. ⟨hal-04893300⟩
-
Sarah Soueges, Emmanuel Faure, Perrine Parize, Fanny Lanternier-Dessap, Hervé Lecuyer, et al.. Real-world multicentre study of cefiderocol treatment of immunocompromised patients with infections caused by multidrug-resistant Gram-negative bacteria: CEFI-ID.. Journal of Infection, 2025, 90 (1), pp.106376. ⟨10.1016/j.jinf.2024.106376⟩. ⟨hal-04885304⟩
-
Nombre de notices déposée
1 032
Taux d'open access

Sujets
Ribavirin
Kidney transplantation
Malaria
Dog
Thymus
Epidermis
Omicron
Humans
SARS-CoV-2
Central nervous system
France
Vitamin D
B cells
Metabolism
Adult
Immune response
Anophthalmia
Pain
Mast cells
Signaling
Prevalence
Skin
COVID-19
HIV-1
Autoimmunity
Infectious disease
Plasmodium falciparum
T cells
Male
Toxoplasma gondii
Pregnancy
Lymphocytes T
Diagnosis
Hepatitis E
Tolerance
Innate immunity
Differentiation
Prader-Willi syndrome
Oxidative stress
Age
Autoantibodies
Antibody
Anaphylaxis
AIDS
Public health
Hepatitis E virus
Female
Organ transplantation
Filaggrin
Cancer
Autoimmune diseases
Psoriasis
Escherichia coli
Placenta
Dendritic cells
Antigen presentation
Lymphocytes
Systemic lupus erythematosus
Prevention
Biomarkers
Risk factors
Obesity
Cholesterol
Chronic kidney disease
Macrophages
Epidemiology
Cytomegalovirus
Lipids
Immunology
Immunotherapy
Apoptosis
HIV
Cytokines
Congenital infection
Multiple sclerosis
NK cells
Asthma
Rheumatoid arthritis
T lymphocytes
Children
Encephalitis
Dupilumab
Immunological synapse
IgE
Inflammation
Cameroon
Extracellular vesicles
Treatment
Atopic dermatitis
Allergy
Regulatory T cells
Vaccination
Transplantation
Human
Therapeutics
Immunosuppression
Vaccine
Liver transplantation
Frailty
Infection